PROVIDEAN REPRODUCTIVA
VACCINE FOR THE PREVENTION OF BOVINE REPRODUCTIVE DISEASES
SYNDROME: REPRODUCTIVE
Bovine respiratory and nervous diseases, also known as BRD, cause huge losses in cattle farms with generally massive outbreaks in younger animals. Viral and bacterial infections that trigger the disease can also generate neurological complications and compromise the viability of pregnancy in pregnant animals.
Vaccination is necessary to prevent these diseases and to get heavier calves.
Each dose of vaccine contains: Infectious Bovine Infectious Rhinotracheitis virus, IBR (≥ 107.5 TCID50%/dose), Bovine Viral Diarrhea Virus, BVDV (≥ 106.5 TCID50%/dose), Bovine Parainfluenza type 3, PI-3 (≥ 107 TCID50%/dose), Mannheimia haemolytica (Pasteurella haemolytica) bacterin (≥ 500 million CFU/dose), Pasteurella multocida (≥ 500 million CFU/dose) and Histophilus somni (Haemophilus somnus) (≥ 100 million CFU/dose), Adjuvant Pilatus GHA500®, Excipients q.s. to 5 ml.
Apply 5 ml subcutaneously only. Shake frequently and before loading each syringe.
Vaccinate from 3 months of age with 2 doses with an interval of 20 days between them. Revaccinate annually. Vaccinate females one month before service. In pregnant females it is recommended to administer 2 doses with an interval of 20 days between them during the sixth and seventh month. The suggested scheme should be adapted to the recommendation of your veterinarian according to the particular needs of each region or farm.
125 ml (25 doses)
250 ml (50 doses)
Keep out of reach of children and domestic animals. Do not subject animals to stress and/or excessive work before and/or after vaccination. Do not administer in parasitized, malnourished, fatigued, or feverish animals, or animals on antibiotic and/or corticosteroid treatment.
Apply this product under the supervision of a veterinary professional. The product can generate a slight local reaction at the application site that disappears progressively. In isolated cases, the vaccine can produce anaphylactic shock, in which case the veterinarian should apply epinephrine at 1‰.
Between 2º and 8º C. Do not freeze. Do not expose to heat or sunlight. Containers should be discarded according to local legislation.
© Tecnovax 2025
We are a biotechnology company with more than twenty years of experience in the development, production and global commercialization of new vaccines and immunotherapies to protect animal life and productivity.
We are a biotechnology company with more than twenty years of experience in the development, production and global commercialization of new vaccines and immunotherapies to protect animal life and productivity.